Managing Coagulation Abnormalities, Bleeding, and Thrombosis in Patients with Cirrhosis
Armando Tripodi, Vincenzo La Mura, Fabio Piscaglia, Bernardo Stefanini, Nicoletta Riva, Walter Ageno · 2026
Read Managing Coagulation Abnormalities, Bleeding, and Thrombosis in Patients with Cirrhosis by Armando Tripodi, Vincenzo La Mura, Fabio Piscaglia, Bernardo Stefanini, Nicoletta Riva, Walter Ageno (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13421529.txt.
Description
Armando Tripodi and co-authors guide clinicians through the clotting tightrope of liver cirrhosis in a 2026 review. A scarred liver makes too little of both clotting and anti-clotting factors, leaving patients balanced on a narrow edge. They can bleed during procedures yet also form dangerous clots. The authors reviewed the current literature to support real decisions.
Their guidance starts with the tests: the standard prothrombin time and its partner do not describe clotting in cirrhosis and should not be used to predict bleeding. Patient and procedure factors judge risk better. Because procedure bleeding is uncommon, blanket preventive measures are often wasted. The review turns to when anticoagulant drugs help or harm. It is a practical map for a famously confusing corner of liver care.
Catalog record
| CREATOR | Armando Tripodi, Vincenzo La Mura, Fabio Piscaglia, Bernardo Stefanini, Nicoletta Riva, Walter Ageno |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |